The RACE to accelerate drug development for children with cancer

Andrew D.J. Pearson; Dominik Karres; Gregory Reaman; Steven G. DuBois; Leona Knox; Nicole Scobie; Gilles Vassal

doi:10.1016/S2352-4642(20)30247-9

The RACE to accelerate drug development for children with cancer

Andrew D.J. Pearson, Dominik Karres, Gregory Reaman, Steven G. DuBois, Leona Knox, Nicole Scobie, Gilles Vassal

Résultats de recherche: Contribution à un journal › !!Comment/debate

6 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	714-716
Nombre de pages	3
journal	The Lancet Child and Adolescent Health
Volume	4
Numéro de publication	10
Les DOIs	https://doi.org/10.1016/S2352-4642(20)30247-9
état	Publié - 1 oct. 2020

Accès au document

10.1016/S2352-4642(20)30247-9

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{ebfb7ad74e6b4e2ea62994767070ecc9,

title = "The RACE to accelerate drug development for children with cancer",

author = "Pearson, {Andrew D.J.} and Dominik Karres and Gregory Reaman and DuBois, {Steven G.} and Leona Knox and Nicole Scobie and Gilles Vassal",

note = "Funding Information: ACCELERATE receives financial support from the Andrew McDonough B+ Foundation. ADJP reports personal fees from Novartis, Takeda, Merck, Celgene, and Lilly, outside the submitted work. SGD reports personal fees from Bayer, and travel expenses from Salarius and Roche, outside the submitted work. All other authors declare no competing interests. The views expressed in this Comment are the personal views of the authors and may not be understood or interpreted as being made on behalf of or reflecting the position of the regulatory agencies or organisations with which the authors are employed or affiliated.",

year = "2020",

month = oct,

day = "1",

doi = "10.1016/S2352-4642(20)30247-9",

language = "English",

volume = "4",

pages = "714--716",

journal = "The Lancet Child and Adolescent Health",

issn = "2352-4642",

number = "10",

}

TY - JOUR

T1 - The RACE to accelerate drug development for children with cancer

AU - Pearson, Andrew D.J.

AU - Karres, Dominik

AU - Reaman, Gregory

AU - DuBois, Steven G.

AU - Knox, Leona

AU - Scobie, Nicole

AU - Vassal, Gilles

N1 - Funding Information: ACCELERATE receives financial support from the Andrew McDonough B+ Foundation. ADJP reports personal fees from Novartis, Takeda, Merck, Celgene, and Lilly, outside the submitted work. SGD reports personal fees from Bayer, and travel expenses from Salarius and Roche, outside the submitted work. All other authors declare no competing interests. The views expressed in this Comment are the personal views of the authors and may not be understood or interpreted as being made on behalf of or reflecting the position of the regulatory agencies or organisations with which the authors are employed or affiliated.

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85090231567&partnerID=8YFLogxK

U2 - 10.1016/S2352-4642(20)30247-9

DO - 10.1016/S2352-4642(20)30247-9

M3 - Comment/debate

C2 - 32822672

AN - SCOPUS:85090231567

SN - 2352-4642

VL - 4

SP - 714

EP - 716

JO - The Lancet Child and Adolescent Health

JF - The Lancet Child and Adolescent Health

IS - 10

ER -